socaltech | Shared With: Everyone - Oct 06 2006 | cabrellis, vp, regulatory, affairs, novartis, cancer, vice, president, socaltechSan Diego-based Cabrellis Pharmaceuticals has named a new Vice President of Regulatory Affairs and Development Operations. Cabrellis said earlier this week that Tracy Lawhon has been appointed to the position, joining the firm from Novartis Pharmaceutical
- socaltech | Shared With: Everyone - Sep 27 2006 | amgen, vectibix, fda, colorectal, cancer, antibudy, erbitux, imclone, socaltech
The U.S. Food and Drug Administration said Wednesday that the agency has approved Thousand Oaks-based Amgen's Vectibix treatment for colorectal cancer. Vectibix is a human monoclonal antibody for treatment of patients with epidermal growth factor receptor
- socaltech | Shared With: Everyone - Aug 17 2006 | celerus, venture, capital, vc, investment, pathology, cancer, socaltech
Santa Barbara-based Celerus Diagnostics said today that it has received $9M in a Series B funding, led by Merriman, Curhan and Ford, the investment bank. Celerus is developing medical devices for rapid cancer diagnostics. The new round of funding brings t
- socaltech | Shared With: Everyone - Aug 08 2006 | cabrellis, cancer, lung, domain, associates, venture, capital, vc, investment, funding, anthracycline, socaltech
San Diego-based Cabrellis Pharmaceuticals, which is developing treatments for cancer, said Monday that it has raised $27.5M in a Series A funding round. Funding came from Domain Associates, Forward Ventures, Lilly Ventures, Novo A/S, ProQuest Investments,
- socaltech | Shared With: Everyone - Jun 23 2006 | chimeracore, synthetic, materials, venture, capital, vc, investment, cancer, chemistry, socaltech
Santa Barbara-based Chimeracore, a company that is developing therapeutics targeted at cancer based on synthetic materials, has received a round of venture funding, socalTECH has learned. The funding, which was not announced publicly, included an investme
- socaltech | Shared With: Everyone - May 15 2006 | decode, illumina, dna, snp, genotyping, diabetes, heart, attack, cancer, socaltech
deCODE Genetics and San Diego-based Illumina have entered into a strategic alliance, said today that the two companies will work together to commercialize DNA-based diagnostics. The two companies said that they will initiate work on molecular diagnostics
- socaltech | Shared With: Everyone - May 12 2006 | medicinova, cancer, asthma, ms, socaltech
San Diego-based MediciNova said this morning it has added two new members to its board of directors. The firm said that it has appointed Arlene M. Morris and Alan W. Dunton to its board. Morris is President and CEO of Affymax, and Dunton is chairman of Ac
Related Content from Around Faves
cancer
-
At a local store that I had been to recently, I was quite impressed by the hair coloring of the clerk there. I told her how good it looked with that dark base and the streaks that looked so natural; as if sun kissed. This led us to talking about how ea...
6 Favers - WilmerStreed - 19 days ago14 Favers
- ClaraSet - 20 days ago14 Favers
